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in 4–5-month-old APP23 mice. In age-matched deltaE9 
mice, in contrast, spine loss was only observed on cortical 
dendrites that were in close proximity to amyloid plaques. 
In both cases, the reduced spine density was caused by 
decreased spine formation. Interestingly, the patterns of 
alterations in spine morphology differed between these two 
transgenic mouse models. Moreover, in APP23 mice, APP 
was found to accumulate intracellularly and its content 
was inversely correlated with the absolute spine density 
and the relative number of mushroom spines. Collectively, 
our results suggest that different pathological mechanisms, 
namely an intracellular accumulation of APP or extracel-
lular amyloid plaques, may lead to spine abnormalities in 
young adult APP23 and deltaE9 mice, respectively. These 
distinct features, which may represent very different mech-
anisms of synaptic failure in AD, have to be taken into con-
sideration when translating results from animal studies to 
the human disease.
Keywords Alzheimer’s disease · Intraneuronal APP · 
Extracellular Aβ · Dendritic spines · Two-photon in vivo 
imaging
Introduction
Alzheimer’s disease (AD) is the most prevalent cause of 
dementia and currently no effective treatment exists. Multi-
ple strands of evidence suggest that amyloid precursor pro-
tein (APP) and its proteolytic fragment, amyloid β-protein 
(Aβ), play a crucial role in the pathogenesis of AD [62]. 
APP is a single-pass transmembrane protein enriched at 
synapses [19]. The highly conserved APP gene is located 
on chromosome 21 and overexpression of APP in Down’s 
syndrome (trisomy 21) causes accumulation of amyloid 
Abstract Alzheimer’s disease (AD) is thought to be 
caused by accumulation of amyloid-β protein (Aβ), which 
is a cleavage product of amyloid precursor protein (APP). 
Transgenic mice overexpressing APP have been used to 
recapitulate amyloid-β pathology. Among them, APP23 
and APPswe/PS1deltaE9 (deltaE9) mice are extensively 
studied. APP23 mice express APP with Swedish mutation 
and develop amyloid plaques late in their life, while cogni-
tive deficits are observed in young age. In contrast, deltaE9 
mice with mutant APP and mutant presenilin-1 develop 
amyloid plaques early but show typical cognitive deficits in 
old age. To unveil the reasons for different progressions of 
cognitive decline in these commonly used mouse models, 
we analyzed the number and turnover of dendritic spines 
as important structural correlates for learning and memory. 
Chronic in vivo two-photon imaging in apical tufts of layer 
V pyramidal neurons revealed a decreased spine density 
Electronic supplementary material The online version of this 
article (doi:10.1007/s00401-015-1421-4) contains supplementary 
material, which is available to authorized users.
 * Jochen Herms 
 jochen.herms@med.uni-muenchen.de
1
 Department for Translational Brain Research, German 
Center for Neurodegeneratione Diseases (DZNE), Ludwig-
Maximilians-University Munich, Munich, Germany
2
 Center for Neuropathology and Prion Research, Ludwig-
Maximilians-University Munich, Feodor-Lynen-Straße 23, 
81377 Munich, Germany
3
 Munich Cluster of Systems Neurology (SyNergy), Ludwig-
Maximilians-University Munich, Schillerstraße 44, 
80336 Munich, Germany
4
 Graduate School of Systemic Neuroscience, Ludwig-
Maximilians-University Munich, Munich, Germany
910 Acta Neuropathol (2015) 129:909–920
1 3
plaques early in life [21]. Through sequential enzymatic 
cleavage by β and γ-secretases, full-length APP is pro-
cessed to yield amyloid beta (Aβ) as well as other frag-
ments. Accumulation of fibrillar Aβ leads to formation 
of senile plaques, the typical neuropathological hallmark 
of AD. Soluble oligomeric Aβ, in contrast, is thought to 
mediate synapse dysfunction and loss, which strongly cor-
relate with cognitive decline in AD [20, 32]. The amyloid 
hypothesis takes the imbalance between Aβ production and 
clearance as the primary cause of AD [20]. Based on this 
hypothesis and the discovery of familial AD mutations that 
facilitate Aβ production, transgenic mouse models overex-
pressing mutant APP and/or presenilins (PS), which form 
part of the γ-secretase complex, have been created to reca-
pitulate AD pathology.
Among the APP transgenic mouse models, APP23 and 
APPswe/PS1deltaE9 (deltaE9) mice have been extensively 
used for exploring AD-related pathology and drug develop-
ment [63]. To recapitulate the pathogenesis of human AD, 
APP23 mouse model overexpresses human APP with the 
Swedish mutation under the murine Thy1 promoter [57], 
while deltaE9 mice express APP with the Swedish muta-
tion controlled by mouse prion protein promoter elements 
together with mutant human PS1 lacking exon 9, which is 
associated with familial AD [29, 52]. Although these two 
transgenic mouse models display neuronal loss, cholinergic 
deficit, cognitive impairments, amyloid plaques and neuro-
inflammation in old age, the onsets of amyloid plaque for-
mation and cognitive decline between them are very differ-
ent in early adulthood [5, 8, 9, 30, 38, 56]. Aβ deposits are 
not observed in APP23 mice younger than 6 months, but 
age-matched deltaE9 mice have already developed plaques 
[28]. Despite the slower progress of amyloid plaque for-
mation, APP23 mice show faster cognitive decline than 
deltaE9 mice. APP23 mice begin to develop cognitive 
deficits at 3 months, while deltaE9 mice do not have typi-
cal impaired memory until 1 year of age [60, 61]. Uncov-
ering and understanding the discrepancies between them 
are important for the utility of particular animal models to 
deepen our knowledge of synaptic failure in AD.
Using in vivo two-photon imaging of cortical layer V 
pyramidal neurons, we found reduced dendritic spine den-
sity in 4–5-month-old APP23 mice. In age-matched del-
taE9 mice, loss of dendritic spines was only observed in 
close proximity to plaques. Furthermore, chronic in vivo 
imaging revealed that spine loss in AD transgenic mouse 
models was the consequence of decreased spine forma-
tion. Also, morphologies of dendritic spines in APP23 
and deltaE9 mice were altered differently. Immunostain-
ing showed accumulated intracellular APP in APP23 mice. 
The amount of intracellular APP was negatively correlated 
with spine density and morphology. These results suggest 
that spine abnormalities in young adult APP23 and deltaE9 
mice might be caused by intracellular APP and extracellu-
lar Aβ deposits, respectively.
Materials and methods
Animals
APP23 (Novartis) and APPswe/PS1deltaE9 mice (Jackson 
Laboratory) [29, 52, 57] were crossed with GPF-M mice 
(Jackson Laboratory) [13] to obtain double-transgenic off-
spring heterozygous for the corresponding genes. All trans-
genic lines were kept on C57BL/6 background. eGFP-pos-
itive littermates without mutant APP and PS1 transgenes 
were used as controls. Only female mice at the age of 
4–5 months were used in this study. All protocols and pro-
cedures were conducted according to the animal protocol 
approved by the Ludwig-Maximilian University Munich 
and the government of Upper Bavaria.
Cranial window implantation and in vivo two‑photon 
imaging
As previously described [24], mice were anesthetized by 
intraperitoneal injection of ketamine/xylazine (130/10 μg/g 
body weight). Subsequently, dexamethasone (6 μg/g body 
weight) was injected intraperitoneally to prevent develop-
ment of cerebral edema. A piece of skull above the soma-
tosensory cortex was removed and replaced with a 4-mm-
diameter coverslip. After a 4-week recovery period, apical 
dendrites originating from layer V pyramidal neurons were 
imaged using a LSM 7MP microscope (Zeiss) equipped 
with a 20× water-immersion objective (1.0 NA, Zeiss). 
Mice were anesthetized with isoflurane and placed on a 
heating pad to maintain the body temperature. Any single 
imaging session lasted no longer than 1 h. In subsequent 
imaging sessions, imaged regions were re-localized based 
on the unique pattern of blood vessels. To stain amyloid 
plaques in vivo, methoxy-X04 (1 mg/kg) was intraperito-
neally injected 24 h before imaging. For overview images, 
424 × 424 × 350 µm3 z-stacks (0.83 µm/pixel) were taken. 
Higher resolution images (0.138 µm/pixel) were used for 
counting dendritic spines.
Spine analysis
Spines were counted manually in ZEN 2011 (Zeiss). 
Due to limitations in resolution in the Z-direction, only 
laterally protruding spines were taken into account, as 
only those could be identified with certainty and classi-
fied morphologically. Spines that had emerged or disap-
peared since the previous imaging session were classified 
as formed or eliminated, respectively. Spine turnover rate 
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(TOR) was calculated as follows: (Nf + Ne)/(2 × Nt × D), 
Nf = formed spines, Ne = eliminated spines, Nt = total 
spines, D = interval days between imaging sessions. For 
morphological analysis, maximum intensity projections 
from in vivo two-photon stacks were used. The length of 
each spine was measured from the tip of the spine head to 
the bottom of the spine neck. Spine head width was defined 
as the length between the left edge of spine head and the 
right edge. Spines were classified into mushroom, stubby 
and thin spines based on their appearances as described 
before [22, 24].
Immunohistochemistry
Following transcardial perfusion with phosphate-buffered 
saline (PBS) and 4 % paraformaldehyde (PFA), mouse 
brains were fixed in 4 % PFA overnight at 4 °C and then 
cut into 65-µm-thick free-floating frontal sections at the 
level of the somatosensory cortex. β amyloid (4G8, Cov-
ance, 1:200), beta-amyloid 40 (139-5, Covance, 1:100), 
and beta-amyloid 42 (11-1-3, Covance, 1:100) and anti-
APP 22C11 (Millipore, 1:20) antibodies were used for 
APP and Aβ staining. Anti-mouse or rabbit Alexa 647 anti-
body (Life technologies, 1:1000) was used as the second-
ary antibody. For spine imaging, sections were incubated 
with anti-GFP coupled with Alexa 488 (Life technologies, 
1:300) and then mounted on glass coverslips using fluores-
cence mounting medium (Dako). For the microscopy of 
cortical areas, LSM 780 confocal microscope (Zeiss) was 
equipped with a 10×/0.3 objective. To image pyramidal 
neurons and dendrites, a 40×/1.4 objective was used and 
212 × 212 × 80 µm3 z-stacks (0.415 µm/pixel) were taken 
for overview images and APP quantification. To quantify 
the relative APP amount, custom-written Matlab software 
was applied to correct for the depth-dependent changes 
inherent to data obtained from brain slices immunostained 
with fluorophor-coupled antibodies. Exponential fitting was 
applied to correct for the reduction in fluorescence inten-
sity toward the center of the brain slice due to decreas-
ing antibody penetration as well as the additional reduc-
tion imposed by light scattering and light absorption over 
the complete depth of the slice. Higher resolution images 
(0.069 µm/pixel) were used for counting dendritic spines.
Statistics
Analyses were performed blinded with respect to mouse 
genotype. The numbers of mice for in vivo two-photon 
imaging were 5–6 per group. 7–12 dendrites were imaged 
in each mouse; the length of each dendrite was 25–35 µm. 
The data are presented as the means for every mouse (round 
symbols) and the means of the means (horizontal line with 
error bars), except for the data shown in Fig. 3, where the 
data from 13 dendrites out of 5 mice, which were located in 
proximity to nascent plaques (50–80 µm), are shown. More 
than 30 neurons from 5 mice were imaged in ex vivo imag-
ing. Results are presented as mean ± SEM and compared 
with controls by one-way ANOVA with Dunnett’s test. Kol-
mogorov–Smirnov test was used for comparing cumulative 
frequency distributions. Extra sum-of-squares F test was 
used when data were fitted a straight line with nonlinear 
regression. p < 0.05 was defined as statistically significant 
with *p < 0.05, **p < 0.01, N.S.: not significant.
Results
Dendritic spine density of layer V pyramidal neurons is 
reduced differently in young adult APP23 and deltaE9 
mice
In this study, we used APP23 and deltaE9 mouse models, 
which both express human APP with the Swedish mutation. 
In deltaE9 mice, mutant human PS1 lacking exon 9 is co-
expressed [29, 52, 57]. These two mouse models develop 
neuropathological hallmarks of AD differently in young 
adulthood. APP23 mice show cognitive deficits before 
amyloid plaque formation while deltaE9 mice develop 
memory loss after Aβ deposition [28, 60, 61].
To examine whether and how AD transgenic mouse 
models develop synaptic pathology in young adulthood, 
we crossed APP23 and deltaE9 mice with GFP-M trans-
genic mice to visualize apical dendrites of layer V pyrami-
dal neurons by in vivo two-photon microscopy (Fig. 1a). 
We found a significant decrease of spine density in APP23 
mice at the age of 4–5 months (0.28 ± 0.01 spines/µm, vs. 
WT 0.38 ± 0.03 spines/µm, Fig. 1b). Because Aβ deposits 
emerge in deltaE9 mice as early as 4 months of age and 
amyloid plaques disturb dendritic spine stability [3, 16], we 
analyzed dendrites in deltaE9 mice that were close and far 
from plaques. Dendrites that were chosen from plaque-free 
overview images (>100 µm from plaques, supplementary 
Figure 1a) did not show spine loss (0.36 ± 0.01 spines/
µm, Fig. 1b), but the ones that were in close proximity to 
plaques (<30 µm from plaques, supplementary Figure 1b) 
displayed a strong decrease in spine density (0.27 ± 0.02 
spines/µm, Fig. 1b).
Imbalance between spine formation and elimination 
causes spine loss
To determine whether spine dynamics are altered in APP23 
and deltaE9 mice, we repeatedly imaged apical dendrites 
1 week apart in the somatosensory cortex. While the spine 
turnover rate in both AD models did not differ from WT ani-
mals (0.038 ± 0.003 vs. 0.042 ± 0.003 vs. 0.039 ± 0.004 
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vs. 0.045 ± 0.003, Fig. 1c), we found that significantly 
fewer new spines emerged in APP23 mice (0.05 ± 0.004 
spines/µm, vs. WT 0.11 ± 0.01 spines/µm, Fig. 1e). In del-
taE9 mice, spine formation was also decreased on dendrites 
that were in proximity to plaques (<30 µm, 0.065 ± 0.003 
spines/µm, Fig. 1e), but not on dendrites far away from 
plaques (>100 µm, 0.099 ± 0.01 spines/µm, Fig. 1e). The 
spine eliminations among WT, APP23 and deltaE9 mice 
(>100 µm and <30 µm) were comparable (0.098 ± 0.004 
spines/µm vs. 0.087 ± 0.008 spines/µm vs. 0.097 ± 0.005 
spines/µm vs. 0.087 ± 0.008 spines/µm, Fig. 1d). These 
results suggest that the decrease in the spine density of 
young adult AD mice is a consequence of an imbalance 
between spine formation and elimination.
Alterations in spine morphology differ between APP23 
and deltaE9 mice
Besides absolute spine density, spine morphology also cor-
relates with dendritic spine function and thus impacts cog-
nitive performance [51]. To examine whether the spine 
morphology of these AD transgenic mouse models is altered, 
we measured spine length and spine head width of the in 
vivo imaged dendritic spines. Spine lengths of dendritic 
spines from APP23 and deltaE9 mice (<30 µm) were signifi-
cantly decreased, while spines from deltaE9 mice (>100 µm) 
showed decreased spine head width (Fig. 2a, b). Moreover, 
we classified the spines according to their morphological 
appearance into mushroom, stubby and thin spines [24]. 
APP23 and deltaE9 mice (>100 µm and <30 µm) showed 
a reduced fraction of mushroom spines (35.0 ± 6.9 %, 
38.2 ± 5.7 % and 44.3 ± 2.7 % vs. WT 59.6 ± 3.5 %, 
Fig. 2c). Furthermore, in APP23 mice and deltaE9 mice 
(<30 µm), the decreases of mushroom spines were accompa-
nied with strong increases in the stubby spines (48.6 ± 6.0 % 
and 42.5 ± 3.7 % vs. WT 19.4 ± 5.2 %, Fig. 2d). However, 
thin spines, but not stubby spines, were increased in del-
taE9 mice (>100 µm, 36.7 ± 5.7 % vs. WT 20.9 ± 2.3 %, 
Fig. 2e). Collectively, these results show that morphological 
alterations of dendritic spines in APP23 and deltaE9 mice, 
are distinct. In addition, these alterations even differ between 
different distances to fibrillar plaques within deltaE9 mice.

































































Fig. 1  Decreased spine density in dendrites of APP23 mice and del-
taE9 mice. a By in vivo two-photon imaging, the same apical den-
drites from layer V pyramidal neurons in the somatosensory cortex 
were repeatedly imaged 1 week apart. Each image is a maximum 
intensity projection of serial sections. White arrowheads point at 
spines formed over 1 week and empty arrowheads point at elimi-
nated spines. Scale bar 10 μm. b Spine densities of apical dendrites 
in WT, APP23 and deltaE9 mice. In deltaE9 mice, dendrites that 
were localized at plaque-free overview images are classified as del-
taE9 (>100 µm) and the ones in close proximity to plaques are named 
as deltaE9 (<30 µm). c Turnover rates of apical dendrites in WT, 
APP23 and deltaE9 (>100 µm and <30 µm) mice. d, e Spines that 
were eliminated (d) and newly formed (e) over 1 week in WT, APP23 
and deltE9 (>100 µm and <30 µm) mice. In WT group, n = 6. In 
APP23 group, n = 6. In deltaE9 (>100 µm) group, n = 5. In deltaE9 
(<30 µm) group, n = 5. **p < 0.01 (ANOVA with Dunnett’s post hoc 
test)
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Spine loss and alterations in spine morphology are 
associated with amyloid plaque growth in deltaE9 mice
In young adult deltaE9 mice, dendrites that were located 
near (<30 µm) and far (>100 µm) away from plaques dis-
played two different patterns of spine abnormalities. 
Close to plaques (<30 µm) a decrease in spine density and 
increase in the fraction of stubby spines were observed. 
Dendrites far away from plaques (>100 µm) did not develop 
spine loss but showed increased fraction of thin spines. 
To investigate whether the alterations of dendritic spine 
abnormalities are correlated with the distance between 
dendrites and plaques, we imaged dendrites that resided 
50–80 µm away from plaques. With amyloid plaque growth 
over 1 month, the distance between dendrites and plaques 
became smaller (from 59.9 ± 2.7 µm to 52.6 ± 2.6 µm, 
Fig. 3a). Meanwhile, dendrites started to develop spine 
loss (Fig. 3b, c). The decrease of spine density was caused 
by reduced spine formation (Fig. 3d). Moreover, the frac-
tion of mushroom spines remained unchanged (Fig. 3e), 
while the fraction of stubby spines increased along with the 
decrease of thin spine fraction (Fig. 3f, g). Taken together, 
these results indicate that amyloid plaques cause manifold 
dendritic spine alterations in deltaE9 mice.
APP accumulates intracellularly in APP23 mice
To exclude the possibility that the decreased spine density 
which we observed in APP23 mice was not caused by the 
close vicinity to amyloid plaques [4], we used methoxy-X04 
to label fibrillar amyloid deposits in vivo [7] and no plaque 
was found in the imaged volumes in APP23 mice at the 
age of 4–5 months(data not shown). Ex vivo immunohisto-
chemical staining with methoxy-X04 further confirmed that 
APP23 mice had not yet developed amyloid plaques (data not 
shown). Furthermore, we stained brain sections using an anti-
body that recognizes both APP and Aβ (4G8). Surprisingly, a 
strong APP/Aβ somatic staining was observed in the cortex of 
4–5-month-old APP23 mice (Fig. 4a). To further clarify the 
identity of the intracellular immunoreactivity, we used anti-
bodies specific to detect Aβ40, Aβ42 and APP. No intracellu-
lar immunoreactivity was detected by Aβ-specific antibodies 
in APP23 mice (Fig. 4c, d). The ability of these antibodies to 
bind Aβ peptides was verified by the detection of extracellular 
Aβ deposits in deltaE9 mice (Fig. 4c, d). In contrast, intra-
cellular APP immunoreactivity was also observed with the 
APP-specific antibody 22C11 in APP23 mice (Fig. 4b). West-
ern blot analysis further confirmed APP23 mice mainly over-













































































































Fig. 2  Dendritic spine morphology changes differently in APP23 
and deltaE9 mice. a, b Cumulative distributions of spine length (a) 
and spine head width (b) in WT, APP23 and deltaE9 (>100 µm and 
<30 µm) mice. a, b **p < 0.01 (Komogornov–Smirnov test). c–e 
Fractions of mushroom (c), stubby (d) and thin spines (e). Represent-
ative classified spines are on the top-left corner. In WT group, n = 6. 
In APP23 group, n = 6. In deltE9 (>100 µm) group, n = 5. In deltE9 
(<30 µm) group, n = 5. c–e *p < 0.05, **p < 0.01 (ANOVA with 
Dunnett’s post hoc test)
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(Supplementary Figure 2). Notably, the expression of APP in 
APP23 mice was higher than in deltaE9 mice (Supplemen-
tary Figure 2), which is in line with previous reports [28, 57]. 
These results suggest that the intracellular accumulations in 
APP23 mice consist of APP, rather than Aβ.
The amount of intracellular APP correlates 
with dendritic spine alterations
In young adult APP23 mice, spine density of cortical 
pyramidal neurons was reduced and spine morphology was 
also changed. To assess if these structural alterations were 
caused by the observed intracellular APP accumulation, the 
amount of APP in the soma of eGFP-labeled cortical layer 
V pyramidal neurons was quantified from brain sections 
(Fig. 5a). Along with the increase of intracellular APP, 
spine densities on apical and basal dendrites of pyramidal 
neurons declined (Fig. 5b, c, f). In addition, the fractions of 
mushroom spines were decreased (Fig. 5d, g), while stubby 
spine fractions were increased (Fig. 5e, h). Besides, the 
accumulation of intracellular APP in CA1 pyramidal neu-
rons also coincided with the decrease of spine density and 
alterations of spine morphology (Supplementary Figure 3). 
Altogether, these results suggest that intracellular accumu-
lation of APP may be responsible for the spine alterations 
in 4–5-month-old APP23 mice.
a Without plaque Near plaque
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Fig. 3  Spine loss and morphological alterations are accompanied by 
amyloid plaque growth in deltaE9 mice. a Maximum intensity projec-
tions of two-photon in vivo images of GFP-labeled dendrites (white) 
and methoxy-X04-labeled plaques (blue) are shown. The distance 
from dendrite to plaque (red arrow line) is reduced after 1 month 
due to plaque growth. Scale bar 40 μm. b Maximum intensity pro-
jected dendrites from a (arrowhead pointed, near plaque) and from 
plaque-free overview images (without plaque) in deltaE9 mice. Scale 
bar 10 μm. c Spine densities of the dendrites that were near plaque 
or in plaque-free area over 1 month. Each dashed line represents one 
dendrite. d Newly formed and eliminated spine densities of the den-
drites that were near plaque or in plaque-free area over 1 month. e–g 
Fractions of mushroom (e), stubby (f) and thin spines (g) in these two 
different dendrites over 1 month. Each dashed line represents one 
dendrite. Paired t test was used for plaque growth-mediated spine 
alterations and unpaired t test was used to compare spine formation 
and elimination between groups. n = 13 in each group. *p < 0.05, 
**p < 0.01
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Discussion
Extracellular Aβ is accepted to be in the center of AD 
pathogenesis due to its neurotoxicity that disrupts multi-
ple physiological processes [53]. Guided by the amyloid 
hypothesis, AD mouse models have been created to reca-
pitulate the cognitive impairments seen in AD patients. 
These mouse models typically express human APP with or 
without PS1 with familial AD mutations, which both cause 
familial forms of AD. Although most of the mouse models 
develop typical amyloid plaques and cognitive deficits with 
age, the pathophysiology in young transgenic mice, reflect-
ing preclinical forms of AD, is less well understood [63]. 
APP23 mice display cognitive impairments before plaque 
formation, while deltaE9 mice develop abundant plaques 
before the decline of cognitive performance. The underly-
ing mechanisms of these discrepancies are still not clear.
The major correlate of cognitive impairment is synapse 
loss, which is closely associated with spine loss as excita-
tory glutamatergic synapses normally reside at dendritic 
spines in the mammalian brain [43]. In addition to absolute 
spine density, the dynamic turnover of spines, termed struc-
tural plasticity, is also involved with learning and memory: 
the formation and elimination of dendritic spines rewire 
neural circuits by establishing or abolishing connections in 
the brain during learning experiences [15]. Thus, it is plau-
sible to examine alterations of dendritic spines as readout 
for structural correlate of cognitive decline in AD trans-
genic mouse models.
In this study, we found that 4–5-month-old APP23 mice 
displayed reduced spine density of cortical layer V pyrami-
dal neurons. In deltaE9 mice, spine loss was only evident 
on dendrites that were located close to plaques. We found 
similar results in the APPswe/PS1L166P mouse model 
[48], which accumulates plaques faster than the deltaE9 
model: here, spines were lost only in the vicinity (<50 µm) 
of plaques, while spines were not altered distant (>50 µm) 
to plaques or before plaques had appeared [3]. These 
results suggest that spine loss mediated by fibrillar amyloid 
plaques occurs only in the immediate vicinity of extracel-
lular Aβ deposits in deltaE9 and APPswe/PS1L166P mice.
The decreased spine densities observed in APP23 and 
deltaE9 mice were caused by reduced spine formation as 
revealed by chronic repetitive in vivo two-photon imag-
ing. Interestingly, we found two different patterns of spine 
morphological alterations in these two transgenic mouse 
models. In APP23 mice, the spine length was reduced and 
the relative proportion of stubby spines was increased. 
In deltaE9 mice, in dendrites close to plaques, the find-
ings were identical. In contrast, the dendrites that were 
far away from plaques in deltaE9 mice showed decreased 
spine head width and elevated thin spine fraction. With 
amyloid plaque growth in deltaE9 mice, dendrites, that 
were originally located 50–80 µm away from plaques, 
became closer to plaques and started to lose spines. This 
effect was accompanied with an increase in the fraction of 
stubby spines. In APP23 mice, APP accumulated intracel-
lularly. A higher content of APP was inversely correlated 
with spine density. Furthermore, an increased fraction of 
mushroom spines and decreased fraction of stubby spines 
were observed in neurons, which contained higher lev-
els of intracellular APP. In summary, our data suggested 
that different pathological mechanisms, intracellular APP 
and extracellular amyloid plaques, might lead to spine 
































Fig. 4  Intracellular accumulation of APP in APP23 mice. a–d Immunohistochemical labeling of intracellular APP/Aβ (4G8, a), intracellular 
APP (22c11, b), Aβ42 deposits (11-1-3, c) and Aβ40 deposits (139-5, d) in WT, APP23 and deltaE9 mice. Scale bar 100 μm
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Dendritic spines are the small bulbous postsynaptic 
elements of the majority of excitatory synapses and serve 
as the basic units for learning and memory [22]. Loss of 
dendritic spines is the major correlate of cognitive impair-
ment in human AD [59]. In agreement with the spine loss 
described before, APP23 mice younger than 6 months show 
memory impairments in multiple cognitive tests, including 
Morris-type water maze test, Y-maze test, Barnes-maze test 
and novel-object recognition test [12, 25, 31, 60]. On the 
other hand, the performance of deltaE9 mice at the same 
age is normal in most cognitive tests (T-maze test, Y-maze 
test, Morris-type water maze test, novel taste neophobia 
test, response acquisition test, Barnes-maze spatial memory 
task with hidden-target strategies), with the exception of 
impairments observed in Barnes-maze spatial memory task 
with cued-target strategies and modified radial-arm water 
maze test [18, 34, 45, 49, 61]. The specific spatial learn-
ing deficit described in young deltaE9 mice may depend on 
dendritic spine shape, rather than a reduced spine number, 
considering that spine loss is only observed on dendrites 
that are localized very close to amyloid plaques, which just 
start to emerge in 4–5-month-old deltaE9 mice [6, 16, 28]. 
With aging, Aβ deposits grow in size. Amyloid plaques 





























































































































































Fig. 5  Increased intracellular APP accumulation is accompanied 
with decreased spine density and altered spine morphologies in the 
somatosensory cortex of APP23 mice. a Maximum intensity projec-
tions of ex vivo images of GFP-labeled neurons (white, A and B) and 
intracellular APP accumulation in layer V pyramidal neurons (black). 
Green dashed circle indicates the area of soma from GFP-labeled 
neurons. Arrows and arrow heads point to basal and apical dendrites, 
respectively. Scale bar 20 μm. b Maximum intensity projected basal 
and apical dendrites from A and B. Scale bar 10 μm. c–e The dot 
plots are the intensity of intracellular APP in basal dendrites from 
layer V pyramidal neurons vs. spine density, mushroom and stubby 
fractions separately. Straight lines are fitted by nonlinear regression. 
Each dot represents one neuron. f–h The dot plots are the intensity of 
intracellular APP in apical dendrites from layer V pyramidal neurons 
vs. spine density, mushroom and stubby fractions separately. Straight 
lines are fitted by nonlinear regression. Each dot represents one neu-
ron. In basal dendrite group, n = 38. In apical dendrite group, n = 33 
(c–h) *p < 0.05, **p < 0.01 (F test)
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deltaE9 mice. At this age general axon degeneration and 
synapse loss are observed, along with impaired cognitive 
performance [18, 46]. Thus, loss of synapses coincides 
with decline in cognitive performance in these models.
Indeed, there is convincing evidence that not only the 
absolute spine number contributes to cognitive perfor-
mance. In fact, dendritic spine size and shape are known to 
affect various functional parameters relevant for cognition, 
including spine motility, neurotransmitter receptor numbers 
and organelle abundance [33, 51]. Growing evidence shows 
that morphological changes of dendritic spines are asso-
ciated with long-term synaptic plasticity (LTP) [68]. LTP 
increases spine head volume while shortening and widen-
ing spine neck [67]. This morphological plasticity allows 
generating changes in electrical properties of dendritic 
spines, which serve as isolated electrical compartments. For 
instance, it has been shown that shorter spine necks lead to 
larger depolarization while longer necks generate smaller 
somatic potentials [1]. It is believed that different types of 
memories need to obey different electrophysiological rules, 
and thus require morphological diversities of spines [51]. 
Along with changes in spine density, distinct alterations of 
spine morphology in APP23 mice and deltaE9 mice might 
also result in the different cognitive impairments described 
before [12, 18, 25, 31, 34, 45, 49, 60, 61]. Layer V pyrami-
dal neurons in the somatosensory cortex are involved in 
motor learning [14, 64–66] and the formation of new den-
dritic spines correlates with the performance after learning 
[66]. While most behavioral tests focus on hippocampus-
dependent memory tasks, the resulting behavior results 
from a complex interplay of various brain regions, in which 
somatosensory cortex neurons may play crucial roles. Thus, 
the alterations of dendritic spines which we found may well 
reflect part of the behavioral phenotype observed in these 
mice. Yet, the susceptibility of spines to the various toxic 
insults due to the overexpression of APP and its cleavage 
products may differ between brain regions, between differ-
ent functional locations within a neuron (e.g. between api-
cal and basal dendrites) or with the age of the experimental 
animals. Therefore, the relation of dendritic spine loss in 
layer V pyramidal neurons to cognitive dysfunction is not 
certain.
Compared to APP23 mice, deltaE9 mice harbor an addi-
tional transgene of a familial AD mutation in PS1 with a 
deletion of exon 9, accelerating the cleavage of APP and 
thereby Aβ formation. In consistence with previous studies 
[10, 16], extracellular amyloid plaques have developed in 
4–5-month-old deltaE9 mice but not APP23 mice. Being 
the abnormal protein aggregates that characterize human 
AD, Aβ deposits are one of the biomarkers for AD neuro-
pathologic assessment [26]. Aβ production and aggregation 
might initiate serial molecular cascades, thus lead to clini-
cal AD [20]. This amyloid cascade hypothesis seems to be 
feasible in early-onset AD, which is known to be caused 
by mutations of genes that increase Aβ accumulation [27]. 
However, as early-onset AD only accounts for a few per-
cent of AD cases and the correlation between cognitive 
decline and Aβ deposits is weak [2, 17], alternative expla-
nations for the pathogenesis of AD have emerged [36, 40].
In contrast to age-matched deltaE9 mice, only a minor 
soluble Aβ burden was found in the brains of young APP23 
mice [10, 37, 61]. Overexpressed APP in APP23 mice is 
predominantly localized intracellularly and the mecha-
nisms of this aberrant accumulation and its relevance in 
sporadic AD need to be further investigated. Interestingly, 
a number of studies have reported increased amount of 
APP mRNA in AD patients [39, 41, 47], indicating that 
up-regulated transcriptional activity of APP may also con-
tribute to AD pathophysiology. Moreover, accumulated 
APP has been found in dystrophic neuritis of AD [11, 54]. 
It is therefore tempting to speculate that intraneuronal 
accumulation of APP and/or its cleavage products includ-
ing Aβ in AD may also contribute to synaptic damage [44, 
58]. Indeed, an extra copy of the APP gene can cause neu-
ronal dysfunction and symptoms similar to those seen in 
AD [42]. APP gene triplication in Down’s syndrome and 
APP locus duplication in rare families lead to clinical AD-
like pathology in adults and result in early-onset dementia 
[21, 50]. The neurotoxicity of APP is largely thought to be 
caused by its proteolytic fragments. Besides Aβ, other pro-
teolytic APP fragments, such as C83, C99 and APP intra-
cellular domain, could also be involved in AD pathogen-
esis [55]. By regulating gene expression, these derivatives 
may give rise to neuronal degeneration [35, 55]. Addi-
tionally, through the direct interaction between APP and 
N-methyl-d-aspartate receptors (NMDARs), overexpressed 
APP up-regulates the expression of NMDARs and thus 
may contribute to neuronal toxicity by disrupting synaptic 
homeostasis [23].
To conclude, despite the fact that APP23 and deltaE9 
mice show similar cognitive impairments and neuropathol-
ogy in advanced age, our data clearly show different den-
dritic spine abnormalities in these two transgenic mouse 
models in young adulthood. Our findings imply that syn-
aptic failure in these mouse models may be caused by dif-
ferent mechanisms in an age-dependent manner. Since the 
mechanisms underlying the development of sporadic AD 
are still uncertain, this study has significant implications for 
the analysis of distinct AD transgenic mouse models during 
preclinical drug evaluation for treatment of early-stage AD.
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